About Shaanxi Micot Technology
Shaanxi Micot Technology is a company based in China founded in 2007 by Wang Bing. Shaanxi Micot Technology has raised $72.16 million across 2 funding rounds from investors including Tasly, NLVC and Detong Capital. Shaanxi Micot Technology operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and vivitide, among others.
- Total Equity Funding$72.16M (USD)
in 2 rounds
- Latest Funding Round$55.92M (USD), Series B
May 2021
- InvestorsTasly
& 2 more
Funding Insights of Shaanxi Micot Technology
Shaanxi Micot Technology has successfully raised a total of $72.16M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $55.92 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $72.16M
- Total Rounds 2
- Last Round Series B β $55.92M
- First Round $16.24M
(Oct 2019)
- Investors Count 3
All 2 funding rounds of Shaanxi Micot Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $55.92M | Series B | β | β | |
| Oct 2019 | $16.24M | Seed | β | Northern Light Venture Capital |
3 investors in total: 3 institutional.
Investors in Shaanxi Micot Technology
Shaanxi Micot Technology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Tasly, NLVC and Detong Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of early stage venture capital focused on technology companies | – | nlvc.com | Menlo Park, United States | |
- | – | dtcap.com | - | |
Traditional Chinese medicines are manufactured and distributed globally. | 1994 | tasly.com | Tianjin, China |
Investor details for Shaanxi Micot Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Shaanxi Micot Technology
1 people are tracked at Shaanxi Micot Technology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Wang Bing | Founder Chairman & President | Leadership |
Complete people profiles for Shaanxi Micot Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Shaanxi Micot Technology
Shaanxi Micot Technology is a publicly listed company on the HKEX with ticker symbol 2335 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Jun 2026
- Listed onHKEX: 2335
- Listed entityShaanxi Micot Pharmaceutical Technology Co., Ltd. Class H
- Exchange sectorHealth technology
- ISINCNE100007Q79
- Share price22.08 HKD (-2.47% on the day) · 2026-10-09
- Market capitalisation7,334,820,036.00 HKD
- EPS (diluted, trailing year)-1.25 HKD
- Volume (last session)327,800
Timeline of Shaanxi Micot Technology
4 dated milestones of Shaanxi Micot Technology across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Shaanxi Micot Technology is founded.
- Funding First funding round of $16.2M.
- Funding Latest funding round, Series B, of $55.9M.
- IPO Lists on the stock exchange (IPO).
Competitors of Shaanxi Micot Technology
Shaanxi Micot Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and vivitide, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enzene.com | 2006 | Pune, India | $50M | 10 | Company specializing in development of Biosimilars | |
| hybio.com.cn | 1998 | Shenzhen, China | $15M | – | Polypeptide drugs and APIs are developed and manufactured. | |
| ambiopharm.com | 2006 | North Augusta, United States | $24M | 186 | CDMO and analytical services for peptide development are provided. | |
| ocelotbio.com | 2020 | San Diego, United States | $36M | – | Ocelot Bio is a CDMO specializing in peptide manufacturing services. | |
| vivitide.com | 1983 | Gardner, United States | – | 94 | Drug development services for neoantigen peptides and antibodies are provided. | |
| aperiambio.com | 2019 | United States | $13M | – | Industrial and therapeutic proteins are manufactured by Aperiam Bio. | |
| ramedapharma.com | 1994 | Giza, Egypt | – | 2 | Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products | |
| maruho.co.jp | 1915 | Osaka, Japan | – | – | Conducts R&D and manufactures ethical drugs for healthcare applications. | |
| san-bangchem.com | 2016 | Changchun, China | $2.99M | – | Manufacturer of photoelectric materials (OLED), pharmaceutical intermediates and bioactive products |
Detailed competitors of Shaanxi Micot Technology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shaanxi Micot Technology
Complete news archive for Shaanxi Micot Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Shaanxi Micot Technology
10 companies that operate in the same segment as Shaanxi Micot Technology (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shaanxi Micot Technology
Shaanxi Micot Technology was founded in 2007 and raised its 1st funding round 12 years after it was founded.
Shaanxi Micot Technology is headquartered in China.
Shaanxi Micot Technology is a funded company, having raised a total of $72.16M across 2 funding rounds to date. The company's 1st funding round was a Seed of $16.24M, raised on Oct 2019.
Shaanxi Micot Technology was established in 2007 in China. Drug research and development services are offered, targeting cardiovascular and metabolic diseases within the pharmaceutical sector. Operations involve support for drug discovery, preclinical studies, and related processes. Expertise is applied to address unmet needs in these therapeutic areas, with activities based primarily in the Chinese market. Leadership is provided by founder Wang Bing as chairman and president.
Shaanxi Micot Technology's top competitors include Enzene Biosciences, Hybio Pharmaceutical and AmbioPharm.
Yes, Shaanxi Micot Technology is publicly traded on HKEX under the ticker symbol 2335.